Drug research takes a long time. The drugs that cause this debate are drugs that the pharmaceutical companies decided to research decades ago, when they seriously expected people would respect intellectual property rights more than human lives.
Now that they know better, they will probably go invent a new Viagra or something instead of inventing something useful which can be prematurely generified for the common good.
Lots of people are already dying of antibiotic resistant bacteria, for example, and that's a problem likely to get worse over time.
EDIT: Not to mention having their own research and development. I bet it's cheaper to research stuff in India, but evil selfish pharma companies don't want to invest in research in countries with poor intellectual properties protection.
You can live a perfectly fine, if frugal, life in India on USD $2 a day, but not if you have to pay for USD $1 tablets.
I thought any lab could do that. Isn't the research part the most difficult and expensive part?
>if a pharma company takes an old drug and a new chemical to it to change its effects slightly, the patent is renewed, and that way it it never actually becomes 'old' enough
I've heard about this happening with 'me-too' drugs and bullshit antidepressants. Does it happen as well with essential life saving medicine?
"The Pharmaceutical industry in India is the world's third-largest in terms of volume and stands 14th in terms of value."
"Indian companies carved a niche in both the Indian and world markets with their expertise in reverse-engineering new processes for manufacturing drugs at low costs."[2]
There is skill involved in reverse-engineering new processes for manufacturing drugs.
Does it happen with essential life saving medicine?
Yes.
"...Glivec, a medicine for chronic myeloid leukemia"[1]
"The Supreme Court defended India’s right to deny patents to incremental improvements. It ruled that Glivec was merely a new form of an older drug and did not constitute a patentable invention. “This is a huge relief,” said Unni Karunakara, the president of Médecins Sans Frontières, which cares for patients in poor countries. Novartis is less pleased, declaring that the ruling “discourages future innovation in India."
Did you previously think pharmaceutical companies care about people's lives more than profit? I'm sorry to disappoint.
[1] http://webcache.googleusercontent.com/search?client=safari&r...
[2] https://en.wikipedia.org/wiki/Pharmaceutical_industry_in_Ind...
the only thing holding the system in place are the patents, not the knowledge.
This is money grab. There is no way to justify it. If they think the money isn't there, they are more than welcome to stop the research.
What's more appropriate to ask though is how do developing/under-developed countries compete with the money spending power of west. Are the poor people forever destined to look for aid from the west? If they ain't creating all the drugs, they ain't creating all the horrible diseases either. Many tribes were perfectly happy and healthy until the intruders affected their ecosystem.